161 related articles for article (PubMed ID: 37679334)
1. TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.
Vashisht M; Ge H; John J; McKelvey HA; Chen J; Chen Z; Wang JH
Cell Death Dis; 2023 Sep; 14(9):599. PubMed ID: 37679334
[TBL] [Abstract][Full Text] [Related]
2. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
3. TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.
Woolaver RA; Wang X; Dollin Y; Xie P; Wang JH; Chen Z
J Immunol; 2018 Dec; 201(11):3421-3430. PubMed ID: 30341187
[TBL] [Abstract][Full Text] [Related]
4. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
[TBL] [Abstract][Full Text] [Related]
5. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
[TBL] [Abstract][Full Text] [Related]
6. TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.
Pérez-Chacón G; Llobet D; Pardo C; Pindado J; Choi Y; Reed JC; Zapata JM
J Immunol; 2012 Jul; 189(2):1053-61. PubMed ID: 22711886
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
[TBL] [Abstract][Full Text] [Related]
8. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
Gardam S; Sierro F; Basten A; Mackay F; Brink R
Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
[TBL] [Abstract][Full Text] [Related]
9. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
10. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling.
Guasparri I; Wu H; Cesarman E
EMBO Rep; 2006 Jan; 7(1):114-9. PubMed ID: 16311516
[TBL] [Abstract][Full Text] [Related]
11. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
13. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
[TBL] [Abstract][Full Text] [Related]
14. TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice.
Zhang L; Blackwell K; Workman LM; Gibson-Corley KN; Olivier AK; Bishop GA; Habelhah H
J Cell Sci; 2016 Apr; 129(7):1455-67. PubMed ID: 26872784
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.
Zhang B; Wang Z; Li T; Tsitsikov EN; Ding HF
Blood; 2007 Jul; 110(2):743-51. PubMed ID: 17405906
[TBL] [Abstract][Full Text] [Related]
16. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
18. Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.
Edwards SK; Han Y; Liu Y; Kreider BZ; Liu Y; Grewal S; Desai A; Baron J; Moore CR; Luo C; Xie P
Leuk Res; 2016 Feb; 41():85-95. PubMed ID: 26740054
[TBL] [Abstract][Full Text] [Related]
19. Brief Research Report Regional Difference in TRAF2 and TRAF3 Gene Mutations in Colon Cancers.
Moon SW; Son HJ; Choi EJ; Yoo NJ; Lee SH
Pathol Oncol Res; 2021; 27():625438. PubMed ID: 34257589
[No Abstract] [Full Text] [Related]
20. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
